https://etira.life/wp-content/uploads/2025/04/Unknown.png
1400
1266
Etira
https://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.png
Etira2025-04-24 14:25:482026-01-02 11:01:32Preclinical data on ERX-208 and ERX-315 to be presented at AACR 2025Breakthroughs that
See news releases about Etira, our stellar team,
https://etira.life/wp-content/uploads/2025/04/Unknown.png
1400
1266
Etira
https://etira.life/wp-content/uploads/2023/11/etira-life-logo-home.png
Etira2025-04-24 14:25:482026-01-02 11:01:32Preclinical data on ERX-208 and ERX-315 to be presented at AACR 2025
Second site activated for ERX-315 trial
NewsAdelaide, Australia – March 17, 2025: Etira, a clinical-stage biopharmaceutical company developing new cancer therapies, has now activated a second site for recruitment of patients for the ERX-315-001 clinical trial at Cancer Research South…

ERX-315 Phase 1 Clinical Trial Update
NewsSydney, Australia – February 20, 2025: Etira, a clinical-stage biopharmaceutical company developing new cancer therapies, announced today that a patient has been successfully dosed at Dose Level Three (DL3) of ERX-315 in its Phase 1 trial…

Dr. Raj appointed as Etira Chief Medical Officer
NewsDallas, TX - December 2, 2024: Etira, a clinical-stage biotechnology company pioneering novel approaches to treating cancer by inducing endoplasmic reticulum stress, today announced the appointment of Etira Co-Founder, Ganesh Raj, M.D., Ph.D.,…

First patient dosed in ERX-315-101 Clinical Trial
NewsSydney, Australia - November 18, 2024: We are excited to announce that the first patient in our ERX-315-101 Phase 1 clinical trial has successfully received their first doses of ERX-315 at The Kinghorn Cancer Center (TKCC) in Sydney, Australia.…

Drs. Jenkins and Stebbing join Etira Board
NewsDallas, TX – October 8, 2024: Etira, a clinical-stage biopharmaceutical company developing new cancer therapies, announced the appointment of Annalisa Jenkins, MBBS, FRCP and Justin Stebbing, BM, BCh, MA (oxon), FRCP FRCPath, MD, PhD to…


Where to find us
Dallas Office:
3033 Irving Blvd,
Dallas. TX. 75247
Mailing Address:
3060 Pegasus Park Dr.
Dallas. TX. 75247

